Forbes

A field study found more than 500 Bundibugyo Ebola cases in Mongbwalu from mid-January, months before Congo declared the outbreak and earlier than any model suggested.

Blended genome–exome sequencing reads key regions deeply and the rest of the genome shallowly, cutting costs and ancestry bias while preserving genetic insight.

37 million Americans have no sleep specialist. 40 million rural residents lack primary care. Discover why these three fields are in crisis and what's being done about it.

Deborah Kan, founder of "Being Patient," established the platform after her mother's Alzheimer's diagnosis to bridge critical information gaps for affected families.

Beyond nausea: a doctor describes research that reveals hidden side effects of Ozempic, Wegovy and Mounjaro, from hair loss to menstrual changes and how to address them.

A Continuing Resolution from the U.S. Senate Appropriations Committee would delay implementation of the Trump administration's new OMB rule to at least December 11.

The U.S. mortality rate reached a record low in 2025. But it lags behind peers due to persistent issues like chronic disease, gun violence and unequal healthcare access.

New research on hypertrophic cardiomyopathy shows how gene changes in heart muscle proteins drive sudden cardiac death, turning genetic results into clear guidance.

As more people go without insurance, hospital revenues decline, insurance premiums throughout the system increase and medical debt levels rise.

From receptionists to LPNs and medical assistants, jobs in doctor practices see pay increases of 15% to 30% over five years, Medical Group Management Association said.

A public health expert fact checks RFK Jr.'s recent contentious interview on CNN with facts on vaccines, COVID-19 and measles.

A doctor breaks down misinformation about vaccines and provides facts to parents deciding whether to vaccinate their children.

Though FDA would normally follow a panel’s advice to move ahead with compounded peptides, it’s unclear how it will act, because FDA staff are opposed to easing access.

Major Medicare Advantage insurer Humana is withdrawing from certain markets for 2027, a move expected to be mirrored by other companies facing rising medical expenses.

Medicare patients are getting access to GLP-1s for obesity through the Bridge program. But questions linger regarding eligibility criteria, prior authorization and costs.